Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 7, 2012
- Accepted in final form January 5, 2013
- First Published February 6, 2013.
Article Versions
- Previous version (February 6, 2013 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Liesi E. Hebert, ScD,
- Jennifer Weuve, ScD,
- Paul A. Scherr, PhD, ScD and
- Denis A. Evans, MD
- Liesi E. Hebert, ScD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH R01NR010211 PI 2009-2012, NIH R01AG030544 biostatistician 2008-2011, NIH R01AG009966 biostatistician 2008-2010, NIH RO1AG011101 epidemiologist 2009-2011, NIH RC2AG036650 biostatistician 2009-2011
NONE
a contract is under consideration with the Alzheimer's Association to cover some of the costs of this work
NONE
NONE
NONE
NONE
NONE
NONE
- Jennifer Weuve, ScD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Fidelity Foundation,(2) Alzheimer's Association
NONE
NONE
NONE
NONE
(1) NIH-NIEHS 5P30ES000002-45/Pilot (4577), PI, 2008-2011, (2) NIH-NIEHS/R21ES016829-01A1, PI, 2009-2011, (3) NIH-NIEHS/R21ES019712, co-investigator, 2010-2013, (4) NIH-NIEHS/R21ES020404, PI, 2012-2014
NONE
(1) Alzheimer's Association NIRG-12-242395, PI, 2012-2014
NONE
NONE
NONE
NONE
NONE
NONE
- Paul A. Scherr, PhD, ScD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Rush Institute for Healthy Aging
NONE
NONE
NONE
NONE
Employee of Centers for Disease Control and Prevention (CDC)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Denis A. Evans, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Principal Investigator or Co-Investigator) of NIH grants AG11101, AG036650, AG030146, AG10161, AG021972, ES10902, NR009543, HL084209, and AG12505l
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to Dr. Hebert: liesi_hebert{at}rush.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophyAndrew J. Westwood, Alexa Beiser, Charles DeCarli et al.Neurology, April 04, 2014 -
Article
Inverse occurrence of cancer and Alzheimer diseaseA population-based incidence studyMassimo Musicco, Fulvio Adorni, Simona Di Santo et al.Neurology, July 10, 2013 -
Article
Very Old Women at Highest Risk of Dementia and Alzheimer's DiseaseIncidence Data from the Kungsholmen Project, StockholmL. Fratiglioni, M. Viitanen, E. von Strauss et al.Neurology, January 01, 1997 -
Article
Midlife personality and risk of Alzheimer disease and distressA 38-year follow-upLena Johansson, Xinxin Guo, Paul R. Duberstein et al.Neurology, October 01, 2014